Catalyst Wire Dossier Catalyst Wire Dossier

BAFFR CAR-T

· Guangzhou Bio-gene Technology Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAFFR CAR-T, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors [EARLY_Phase 1]

See pricing